Basic Information
| LncRNA/CircRNA Name | LINC00645 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | qPCR, Luciferase reporter assay, Western blot |
| Sample | GBM tissues,cell lines(U251, T98G, LN229, A172,SHG44) |
| Expression Pattern | up-regulated |
| Function Description | In the present study, linc00645 expression was significantly upregulated in GBM tissues and cell lines. |
| Pubmed ID | 31558707 |
| Year | 2019 |
| Title | Long non-coding RNA linc00645 promotes TGF-?-induced epithelial-mesenchymal transition by regulating miR-205-3p-ZEB1 axis in glioma. |
External Links
| Links for LINC00645 | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |